J. Cross

发表

Anticancer Ruthenium Complexes with HDAC Isoform Selectivity

R. Pal, T. R. Blower, James W. Walton, 2020, Molecules.

Anticancer RuII and RhIII Piano-Stool Complexes that are Histone Deacetylase Inhibitors.

T. R. Blower, James W. Walton, J. Gill, 2016, ChemPlusChem.

Self-assembly of a heteroleptic one-dimensional chain comprising different dinuclear meso-helicates in the solid-state.

M. Hardie, Lindsay P. Harding, J. Cross, 2013, Chemical communications.

Steric control of the formation of dinuclear double helicate and dinuclear meso-helicate assemblies.

D. Cooke, Lindsay P. Harding, J. Cross, 2013, Chemical communications.

A ‘click’ chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras

S. Cowley, J. Hodgkinson, J. Cross, 2022, RSC medicinal chemistry.

Pyridylphosphinate metal complexes: synthesis, structural characterisation and biological activity.

D. Yufit, M. Jain, James W. Walton, 2016, Dalton transactions.

Intranasally administered S-MGB-364 displays antitubercular activity and modulates the host immune response to Mycobacterium tuberculosis infection

Fraser J. Scott, F. Brombacher, R. Guler, 2022, The Journal of antimicrobial chemotherapy.

Truncated S-MGBs: towards a parasite-specific and low aggregation chemotype

M. Barrett, A. Khalaf, C. Suckling, 2021, RSC medicinal chemistry.

Perfluorinated HDAC inhibitors as selective anticancer agents.

P. Dyson, James W. Walton, Tina Riedel, 2017, Organic & biomolecular chemistry.